Preclinical trials have likewise demonstrated that adoptive transfer of CD4+CD25 + Treg cells into rats with PAH reduces HTN to immunocompetent control rat levels (Jafri and Ormiston, 2017). Here, CD4 is linked to hypertensive disorder.